StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance NASDAQ:CALA opened at $0.03 on Monday. The company has a 50-day moving average price of $0.04 and a […]

Related Keywords

South San Francisco ,California ,United States ,Calithera Biosciences ,Renaissance Technologies ,Goldman Sachs Group Inc ,Calithera Biosciences Company Profile ,Vanguard Group Inc ,Calithera Biosciences Inc ,Nasdaq ,Alyeska Investment Group ,Affinity Asset Advisors ,Free Report ,Asset Advisors ,Goldman Sachs Group ,Sachs Group ,Get Free Report ,Calithera Biosciences Daily ,Nasdaq Cala ,Ocala ,Medical ,Initiated Coverage ,Stocknews Com ,